Sign In
Buy TOMDF
$0.000001
+0 (+0%)
At Close: Jun 02, 2026
Todos to Present at Upcoming Emerging Growth Conference
07:39am, Tuesday, 17'th Aug 2021
New York, NY, and Tel Aviv, ISRAEL, Aug. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, tod
Update: Todos Medical Receives Trademark Notice of Allowance from USPTO for Its 3CL Protease Inhibitor Dietary Supplement Tollovid™
10:40am, Thursday, 05'th Aug 2021
New York, NY, and Tel Aviv, ISRAEL, Aug. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, toda
Todos Medical Receipt Notice of Allowance from USPTO for 3CL Protease Inhibitor Dietary Supplement Tollovid™
09:32am, Thursday, 05'th Aug 2021
New York, NY, and Tel Aviv, ISRAEL, Aug. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today
Todos Medical makes final payment to close Provista Diagnostics acquisition
08:35am, Monday, 02'nd Aug 2021
Todos Medical Ltd said it has made the final payment of $1.25 million to complete its $10 million acquisition of US-based Provista Diagnostics Inc, a medical diagnostics firm that owns the intellectua
Todos Medical Makes Final Payment to Close Provista Diagnostics Acquisition
07:32am, Monday, 02'nd Aug 2021
Company to ramp up marketing efforts for Provista's automated capabilities for COVID-19 PCR testing, variant identification, and neutralizing antibody testing
Todos Medical hires CRO Innvocept Global Solutions to manage two Tollovir coronavirus trials in India
11:38am, Wednesday, 28'th Jul 2021
Todos Medical Ltd said it expects patient enrollment to begin for two Phase 2/3 clinical trials for its Tollovir drug candidate in the third quarter this year after it hired Indian contract research o
Todos Medical Retains CRO for COVID-19 Outpatient and Inpatient Phase 2/3 Clinical Trials for Oral Antiviral 3CL Protease Inhibitor Tollovir
08:58am, Wednesday, 28'th Jul 2021
New York, NY, and Tel Aviv, ISRAEL, July 28, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today
Todos Medical receives new FDA Certificate of Free Sale for its Tollovid Daily immune system support
10:51am, Thursday, 22'nd Jul 2021
Todos Medical Ltd reports that the US Food and Drug Administration (FDA) has granted a new Certificate of Free Sale for Tollovid Daily, the newest member of the company's Tollovid dietary supplement p
Wall Street starts on back foot
10:03am, Monday, 19'th Jul 2021
10am: Proactive North America headlines: Todos Medical Ltd (OTCQB:TOMDF) to launch cPass SARS-CoV-2 neutralizing antibody detection kit Logiq Inc (NEO:LGIQ) (OTCQX:LGIQ) promotes Steven Hartman to chi
Todos Medical to launch cPass SARS-CoV-2 neutralizing antibody detection kit
09:47am, Monday, 19'th Jul 2021
Todos Medical Ltd (OTCQB:TOMDF) has entered into a distribution agreement with Fosun Pharma for the cPass SARS-CoV-2 Neutralizing Antibody Detection Kit. The kit has received Emergency Use Authoriza
Todos Medical to Launch EUA Authorized cPass SARS-CoV-2 Neutralizing Antibody Kit Through Agreement with Fosun Pharma
08:31am, Monday, 19'th Jul 2021
New York, NY, and Tel Aviv, ISRAEL, July 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today
Todos Medical names Ilanit Halperin corporate controller as company prepares for its next growth stage
11:15am, Wednesday, 07'th Jul 2021
Todos Medical Ltd (OTCQB:TOMDF) has appointed Ilanit Halperin corporate controller as the Israel-based company prepares for its next growth stage. A certified public accountant, the company said H
Todos Medical Appoints Ilanit Halperin, CPA as Corporate Controller
09:20am, Wednesday, 07'th Jul 2021
� CEO to present at The Emerging Growth Conference on July 7th, 2021 at 11:30am ET
Todos Medical in the business of saving lives with early disease detection
11:39am, Friday, 02'nd Jul 2021
Develops proprietary technology for blood-based disease testing Offers a comprehensive suite of coronavirus (COVID-19) testing solutions Developing significant programs in cancer and Alzheimer's diagn
Todos Medical makes progress with TolloTest enrollment as its Tollovir dietary supplement also receives interest
12:06pm, Tuesday, 29'th Jun 2021
Todos Medical Ltd (OTCQB:TOMDF) has revealed that it continues to make progress with enrollment of its Phase 2 clinical trial to treat hospitalized coronavirus (COVID-19) patients in Israel, with its
